Phase 3
Completed N=152
Effect of Phenazopyridine on Prolapse Surgery Voiding Trials
Urinary Retention Postoperative
Source: ClinicalTrials.gov NCT03065075 ↗
Enrolled (actual)
152
Serious AEs
0.7%
Results posted
Mar 2019
Primary outcomePrimary: Number of Participants With Postoperative Urinary Retention After Pelvic Organ Prolapse Surgery (INTENT-TO-TREAT) — 30; 25 Participants
◆ Published Evidence
Emerging
6citations · ~1 / year
The Effect of Phenazopyridine on Immediate Postoperative Voiding After Prolapse Surgery: A Randomized Controlled Trial.
Summary
To determine if phenazopyridine reduces the rate of postoperative urinary retention after pelvic organ prolapse surgery.
Linked Publications
-
The Effect of Phenazopyridine on Immediate Postoperative Voiding After Prolapse Surgery: A Randomized Controlled Trial.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Postoperative Urinary Retention After Pelvic Organ Prolapse Surgery (INTENT-TO-TREAT) |
30; 25 | — |
Eligibility Criteria
Inclusion Criteria
- Women undergoing overnight admission after prolapse surgery
Exclusion Criteria
- Unable to provide consent
- Under 18 years of age
- Pregnant women
- Prisoners
- Using intermittent self-catheterization preoperatively
- Neurological disease or spinal cord injury resulting in voiding dysfunction
- Undergoing spinal or epidural anesthesia for the procedure
- Allergy to phenazopyridine
- Renal insufficiency
- Liver disease
- Intra-operative bladder injury necessitating use of prolonged indwelling Foley catheter
Data sourced from ClinicalTrials.gov (NCT03065075) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.